Chemotherapy is currently the most important medical modality of treatment of cancer. Several studies have shown that most, if not all, chemotherapeutic agents exert their anticancer activity by inducing apoptosis (programmed cell death). Although successful treatment of some malignancies has been achieved, most of solid tumors are scarcely responsive to chemotherapeutic agents. The progress made in the area of apoptosis has led to the development of several apoptosis stimulators compounds for the control of cancer. A number of compounds able to activate directly apoptosis by acting on molecules involved in the apoptotic pathway, such as TRAIL receptor, caspases and the Bcl-2 family of proteins have been recently developed. Most are still in the preclinical study, but some have already shown promising results. Other recently developed anticancer drugs induce indirectly apoptosis by acting on targets different from that of classic chemotherapeutic drugs. Here, we review the experimental and clinical results of several promising pro-apoptotic anti-cancer compounds.

Anticancer drugs targeting the apoptotic pathway

SIMONI, Daniele
2005

Abstract

Chemotherapy is currently the most important medical modality of treatment of cancer. Several studies have shown that most, if not all, chemotherapeutic agents exert their anticancer activity by inducing apoptosis (programmed cell death). Although successful treatment of some malignancies has been achieved, most of solid tumors are scarcely responsive to chemotherapeutic agents. The progress made in the area of apoptosis has led to the development of several apoptosis stimulators compounds for the control of cancer. A number of compounds able to activate directly apoptosis by acting on molecules involved in the apoptotic pathway, such as TRAIL receptor, caspases and the Bcl-2 family of proteins have been recently developed. Most are still in the preclinical study, but some have already shown promising results. Other recently developed anticancer drugs induce indirectly apoptosis by acting on targets different from that of classic chemotherapeutic drugs. Here, we review the experimental and clinical results of several promising pro-apoptotic anti-cancer compounds.
Tolomeo, M.; Gebbia, N.; Simoni, Daniele
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1209330
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact